A carregar...

Efficacy and safety of boosted darunavir-based antiretroviral therapy in HIV-1-positive patients: results from a meta-analysis of clinical trials

Darunavir/ritonavir (DRV/r) is a second-generation protease inhibitor used in treatment-naïve and -experienced HIV-positive adult patients. To evaluate efficacy and safety in these patient settings, we performed a meta-analysis of randomized controlled trials. We considered eight studies involving 4...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Antinori, A., Lazzarin, A., Uglietti, A., Palma, M., Mancusi, D., Termini, R.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5869729/
https://ncbi.nlm.nih.gov/pubmed/29588457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-23375-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!